Janwillem Naesens

Insider Reports History

Entity
Individual
Location
128 Spring Street, Building A, Suite 510, Lexington, MA
Signature
/s/ Andrew Gengos, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Janwillem Naesens:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyteir Therapeutics, Inc. Director Common Stock 3.54M $5.98M $1.69 Jun 22, 2021 Indirect
Cyteir Therapeutics, Inc. Director Stock Option (Right to Buy) 14.2K Feb 22, 2022 Direct
Cyteir Therapeutics, Inc. Director Series B Convertible Preferred Stock 0 Jun 22, 2021 Indirect
Cyteir Therapeutics, Inc. Director Series C Convertible Preferred Stock 0 Jun 22, 2021 Indirect

Insider Reports Filed by Janwillem Naesens

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYT Cyteir Therapeutics, Inc. Feb 22, 2022 1 $0 4 Feb 24, 2022 Director
CYT Cyteir Therapeutics, Inc. Jun 22, 2021 4 $5M 4 Jun 24, 2021 Director
CYT Cyteir Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 Director